BenefitsPRO: Employee Benefits News, Trends & Sales Tips

U.S. health insurers prepared to weather rising costs, higher utilization

By Alan Goforth

Higher general inflation in medical supplies and pharmaceuticals, combined with staffing issues, have increased costs for providers.

Read Story

Update

The race is on: Some drugmakers falling behind in developing new weight loss pills

Beyond the numbers: Why price transparency isn't the whole story

Recommended Just For You

Consumer Driven Health Care Stories

June 26, 2023

Cancer patients can't get meds as U.S. drugmakers abandon cheap generics

The main cause, experts agree, is the underlying weakness of the generic drug industry, which are made mostly overseas because U.S. manufacturers are setting their sights instead on high-priced drugs with plump profit margins.

Read

June 26, 2023

GSK settles first Zantac cancer lawsuit (Pfizer and Sanofi settled previously)

More than 70,000 Zantac lawsuits have been filed against the drugmaker and the other pharmaceutical companies, including Pfizer and Sanofi, that sold the heartburn drug.

Read

June 23, 2023

Drug benefit plan trends: Plan sponsors weigh weight management, gene therapy

Health plan sponsors were more liberal in offering a broader range of choices to plan members than were employers, however, sponsors were more likely to shift costs to members than were employers, says a new report.

Read

June 23, 2023

House passes ICHRA bill to give (small) employers a 'cash-for-coverage' option

The Custom Health Option and Individual Care Expenses (CHOICE) Arrangement Act would allow business owners to reimburse employees for individual health insurance plans - and would make that coverage portable.

Read

June 22, 2023

Health care and childcare: What's ahead for Congress in 2023 for consumer-directed plans

With bipartisan consensus in Congress that Americans need help on health care costs, it's likely bills will be introduced to expand the opportunity for individuals to contribute to a health savings account, says the ECFC.

Read

June 22, 2023

'Worst in 30 years': Oncologists urge Congress to fix the cancer drug shortages

There's an acute shortage of key chemotherapy drugs used to treat a wide variety of cancers because manufacturers can't make money off of them, two oncology experts told a House subcommittee.

Read

June 22, 2023

JPMorgan's health arm launches policy guide to push value-based care in employer plans

The commercial insurance market has historically lagged behind government payers on value-based care and requires federal action, recommends JPMorgan Chase's health care arm.

Read

‹ ‹ PREV 135 136 137 ... 727 › NEXT ›

Consumer Driven Health Care

Top Consumer Driven Health Care Stories

U.S. health insurers prepared to weather rising costs, higher utilization

The race is on: Some drugmakers falling behind in developing new weight loss pills

Beyond the numbers: Why price transparency isn't the whole story

Recommended Just For You

Consumer Driven Health Care Stories

Cancer patients can't get meds as U.S. drugmakers abandon cheap generics

GSK settles first Zantac cancer lawsuit (Pfizer and Sanofi settled previously)

Drug benefit plan trends: Plan sponsors weigh weight management, gene therapy

House passes ICHRA bill to give (small) employers a 'cash-for-coverage' option

Health care and childcare: What's ahead for Congress in 2023 for consumer-directed plans

'Worst in 30 years': Oncologists urge Congress to fix the cancer drug shortages

JPMorgan's health arm launches policy guide to push value-based care in employer plans